Overview

Detailed Summary

Sunil Healthcare Limited is a leading manufacturer of Empty Hard Gelatin Capsule Shells in India, known for high-quality production standards.
The company has expanded significantly since its inception, increasing its capsule production capacity to 15 billion shells annually by 2021-22.
Sunil Healthcare also ventured into the food business, under the 'Sunloc Foods' brand, focusing on nuts and edible items like cashews and pistachios.
The company has established subsidiaries in the USA and Mexico to extend its market reach and capitalize on international demand.
Sunil Healthcare's recognition as a 'Star Export House' by the government underscores its substantial export capabilities and market presence.

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 64 Cr
Volatility: Low Risk
P/E Ratio: 16.0
Industry P/E: 34.1
PEG Ratio: 0.8
P/B Ratio: 1.2
52W High: 88.70
52W Low: 56.35

Sales CAGR

1Y: -7.51%
3Y: -10.50%
5Y: 3.53%
10Y: -0.45%

Profit CAGR

1Y: 20.67%
3Y: -68.84%
5Y: —
10Y: -30.21%

ROE

TTM: 5.76%
3Y: 2.42%
5Y: 3.88%
10Y: 4.56%

ROCE

TTM: 6.56%
3Y: 8.06%
5Y: 9.64%
10Y: 11.97%

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
PHRMASI		101.03	69 Cr	3.92	3.86	0.00	8.93	11.29	58.48
SOURCENTRL		105.90	68 Cr	19.96	2.63	0.00	13.20	16.60	8.28
AJOONI		3.92	68 Cr	15.67	0.74	0.00	4.74	5.92	3.58
VINEETLAB		34.40	66 Cr	-6.47	1.49	0.00	-117.41	-22.41	-11.20
JFLLIFE		9.90	65 Cr	10.21	0.83	0.00	13.96	15.84	6.02
SUNLOC		64.90	65 Cr	16.17	1.23	0.00	5.76	6.56	2.44
SAMRATPH		208.80	65 Cr	-19.43	0.95	0.00	-4.86	-2.57	-2.67
Median: 7 Co.	—	64.90	66 Cr	10.21	1.23	0.00	5.76	6.56	3.58

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	23	21	22	20	20	21	23	24	22	20
Expenses	23	19	19	18	18	18	19	20	18	18
Operating Profit	-0.63	2.67	2.21	2.32	2.70	3.03	3.28	3.92	3.63	1.94
OPM %	-2.78	12.53	10.28	11.45	13.20	14.29	14.49	16.67	16.62	9.84
Other Income	3.13	0.68	0.14	0.18	0.53	0.49	0.86	0.42	0.50	0.29
Interest	1.44	1.76	1.51	1.50	1.89	1.56	1.44	1.40	1.66	1.66
Depreciation	1.45	1.43	1.48	1.51	1.69	1.68	1.66	1.64	1.62	1.52
Profit Before Tax	-0.39	0.17	-0.65	-0.51	-0.34	0.28	1.03	1.30	0.84	-0.95
Tax %	48.72	5.88	-6.15	-7.84	-58.82	-28.57	11.65	23.85	30.95	258.95
Net Profit	-0.20	0.15	-0.69	-0.55	-0.54	0.36	0.91	1.00	0.59	1.52
EPS in Rs	-0.20	0.15	-0.67	-0.53	-0.53	0.35	0.89	0.97	0.57	0.57

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	108	91	81	70	91	119	110	90	83	85
Expenses	93	77	70	75	85	102	94	86	73	73
Operating Profit	15	14	11	-4.60	5.29	17	16	4.09	10	11
OPM %	13.86	15.22	14.01	-6.56	5.84	14.59	14.63	4.53	12.30	13.40
Other Income	1.37	2.23	0.18	15	5.58	1.68	4.50	5.22	1.34	2.06
Interest	4.18	5.03	6.58	6.95	5.31	3.49	4.17	5.78	6.46	6.39
Depreciation	4.33	4.78	5.74	6.13	6.11	6.31	7.01	6.09	6.35	6.54
Profit Before Tax	7.89	6.31	-0.81	-3.00	-0.55	9.26	9.48	-2.56	-1.22	0.46
Tax %	36.23	28.79	22.89	21.14	-15.31	30.70	29.54	30.00	-16.53	60.87
Net Profit	5.03	4.49	-0.62	-2.37	-0.64	6.42	6.68	-1.79	-1.42	0.18
EPS in Rs	—	—	-0.67	-4.85	-0.61	6.26	6.51	-1.75	-1.38	3.00
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	10	10	10	10	10	10	10	10	10
Reserves	33	37	37	34	33	40	46	58	57
Borrowings	40	57	49	44	50	35	37	66	69
Other Liabilities	36	38	42	41	27	25	28	24	26
Total Liabilities	119	142	138	130	121	110	121	158	162
Fixed Assets	60	71	69	70	70	70	70	87	94
CWIP	0.12	0.19	2.47	0.01	0.01	1.75	0.01	5.66	0.09
Investments	0.00	0.10	0.11	0.11	1.07	1.03	0.00	0.00	0.00
Other Assets	59	71	66	60	50	37	50	66	68
Total Assets	119	142	138	130	121	110	121	158	162

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	11	5.48	15	4.31	17	23	7.47	-15	12
Cash from Investing Activity	-13	-17	-2.80	-2.52	-11	-4.24	-3.40	-10	-7.70
Cash from Financing Activity	2.23	11	-12	-1.56	-6.42	-19	-3.75	25	-3.87
Net Cash Flow	0.17	-0.67	0.30	0.23	-0.79	-0.29	0.32	-0.51	-0.05

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%
Public	26.37%	26.37%	26.37%	26.37%	26.37%	26.37%	26.37%	26.37%	26.37%	26.37%	26.37%	26.37%
Total Shareholders	7,042	7,081	7,010	6,858	6,594	6,507	6,550	6,541	6,475	6,430	6,399	6,364

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q2 FY19

Investor Presentation

Q4 FY18

Investor Presentation

Q4 FY18

Available on Pro Plan